NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome
- PMID: 22200895
- PMCID: PMC4302414
- DOI: 10.1007/s00467-011-2075-7
NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome
Abstract
Background: Idiopathic nephrotic syndrome (NS) is the most common glomerular disorder of childhood. Invasive biopsy remains the diagnostic method of choice for NS. Prognosis correlates with steroid responsiveness, from sensitive (SSNS) to resistant (SRNS). Neutrophil gelatinase-associated lipocalin (NGAL) has been demonstrated to be a powerful risk marker of chronic kidney disease progression. We set out to determine if urine NGAL can distinguish between patients with SRNS, SSNS, and healthy controls.
Methods: Urine and clinical data were collected from patients at Cincinnati Children's Hospital who were recently diagnosed with active nephrotic syndrome as well as healthy controls. Participants included SRNS (n = 15), SSNS (n = 14), and healthy controls (n = 10). Urinary NGAL was measured by ELISA and normalized to creatinine.
Results: Median NGAL was significantly (p < 0.001) higher in SRNS (172.3 ng/ml, IQR 18.8-789) than both SSNS (6.3 ng/ml, IQR 4.9-9.9) and healthy controls (6.5 ng/ml, IQR 4.2-9.1). The area under the curve (AUC) for NGAL to distinguish SRNS from SSNS was 0.91 (p < 0.0001). NGAL levels demonstrated a significant negative correlation with glomerular filtration rate (r = -0.5, p < 0.001). Results did not change with NGAL corrected for urine creatinine and were independent of the degree of proteinuria.
Conclusions: NGAL levels differentiate SSNS from SRNS and correlate with disease severity in SRNS.
Figures



Comment in
-
Biomarkers of therapeutic response in primary nephrotic syndrome.Pediatr Nephrol. 2013 Jan;28(1):159. doi: 10.1007/s00467-012-2225-6. Epub 2012 Jun 19. Pediatr Nephrol. 2013. PMID: 22710696 No abstract available.
-
Biomarkers of therapeutic response in primary nephrotic syndrome: response.Pediatr Nephrol. 2013 Jan;28(1):161-2. doi: 10.1007/s00467-012-2256-z. Epub 2012 Jul 25. Pediatr Nephrol. 2013. PMID: 22829175 No abstract available.
Similar articles
-
[Expression of urinary neutrophil gelatinase-associated lipocalin and its clinical significance in children with idiopathic nephrotic syndrome].Zhongguo Dang Dai Er Ke Za Zhi. 2013 Jul;15(7):541-5. Zhongguo Dang Dai Er Ke Za Zhi. 2013. PMID: 23866275 Chinese.
-
Association of Urinary Vitamin D Binding Protein and Neutrophil Gelatinase-Associated Lipocalin with Steroid Responsiveness in Idiopathic Nephrotic Syndrome of Childhood.Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):946-956. doi: 10.4103/1319-2442.301201. Saudi J Kidney Dis Transpl. 2020. PMID: 33229759
-
Use of urinary NGAL in steroid-resistant vs. steroid-sensitive nephrotic syndrome: a systematic review and meta-analysis.BMC Nephrol. 2025 Aug 23;26(1):486. doi: 10.1186/s12882-025-04420-9. BMC Nephrol. 2025. PMID: 40849613 Free PMC article.
-
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity?Pediatr Nephrol. 2010 May;25(5):889-97. doi: 10.1007/s00467-009-1397-1. Pediatr Nephrol. 2010. PMID: 20072790
-
Current understandings in treating children with steroid-resistant nephrotic syndrome.Pediatr Nephrol. 2021 Apr;36(4):747-761. doi: 10.1007/s00467-020-04476-9. Epub 2020 Feb 21. Pediatr Nephrol. 2021. PMID: 32086590 Free PMC article. Review.
Cited by
-
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease.Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00605. doi: 10.14309/ctg.0000000000000605. Clin Transl Gastroenterol. 2023. PMID: 37256716 Free PMC article.
-
A Multimodal Fuzzy Approach in Evaluating Pediatric Chronic Kidney Disease Using Kidney Biomarkers.Diagnostics (Basel). 2024 Jul 30;14(15):1648. doi: 10.3390/diagnostics14151648. Diagnostics (Basel). 2024. PMID: 39125525 Free PMC article.
-
Urine Neutrophil Gelatinase Associated Lipocalin to Creatinine Ratio: A Novel Index for Steroid Response in Idiopathic Nephrotic Syndrome.Indian J Pediatr. 2016 Jan;83(1):18-21. doi: 10.1007/s12098-015-1809-0. Epub 2015 Jun 23. Indian J Pediatr. 2016. PMID: 26096867
-
Biomarkers of therapeutic response in primary nephrotic syndrome.Pediatr Nephrol. 2013 Jan;28(1):159. doi: 10.1007/s00467-012-2225-6. Epub 2012 Jun 19. Pediatr Nephrol. 2013. PMID: 22710696 No abstract available.
-
AKI in Children Hospitalized with Nephrotic Syndrome.Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2110-8. doi: 10.2215/CJN.06620615. Epub 2015 Oct 8. Clin J Am Soc Nephrol. 2015. PMID: 26450933 Free PMC article.
References
-
- Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis. 1998;32:72–79. - PubMed
-
- Hari P, Bagga A, Jindal N, Srivastava RN. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol. 2001;16:901–905. - PubMed
-
- Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21:344–349. - PubMed
-
- Roberti I, Vyas S. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus. Pediatr Nephrol. 2010;25:1117–1124. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous